CXCR4 and gastric cancer: In gastric cancer KATO III cells, tatridin A reduces invasiveness by antagonizing PGK1, an oncoprotein that promotes proliferative and anti-apoptotic signaling cascades, along with the downregulation of chemokine receptor 4 (CXCR4) and β-catenin [25].